ES2126644T3 - Reactivo en fase solida y dosificado anticorporal que lo utiliza. - Google Patents

Reactivo en fase solida y dosificado anticorporal que lo utiliza.

Info

Publication number
ES2126644T3
ES2126644T3 ES93903313T ES93903313T ES2126644T3 ES 2126644 T3 ES2126644 T3 ES 2126644T3 ES 93903313 T ES93903313 T ES 93903313T ES 93903313 T ES93903313 T ES 93903313T ES 2126644 T3 ES2126644 T3 ES 2126644T3
Authority
ES
Spain
Prior art keywords
phase reagent
anticorporal
dosage
solid phase
antibody specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93903313T
Other languages
English (en)
Inventor
Takao Koike
Eiji Matsuura
Yoshiko Igarashi
Hisato Nagae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Corp
Original Assignee
Yamasa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Corp filed Critical Yamasa Corp
Application granted granted Critical
Publication of ES2126644T3 publication Critical patent/ES2126644T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/97—Test strip or test slide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN ANTICUERPO ESPECIFICO PARA UN SINDROME DE ANTICUERPO ANTIFOSFOLIPIDO PUEDE SER PROBADO ESPECIFICAMENTE USANDO UN REACTIVO DE FASE SOLIDA ENLAZANDO (BETA)2-GLICOPROTEINA I A UN PORTADOR QUE TIENE UN GRUPO FUNCIONAL Y/O UN RADICAL LIBRE CON UNA CARGA NEGATIVA O UN PAR DE ELECTRONES AISLADOS UNIDOS A SU SUPERFICIE. TAMBIEN UN ANTICUERPO ESPECIFICO PARA UN SINDROME DE ANTICUERPO ANTIFOSFOLIPIDO Y OTRO ANTICUERPO ESPECIFICO PARA UNA ENFERMEDAD INFECCIOSA PUEDE SER DETECTADO DIFERENCIALMENTE USANDO EL REACTIVO ANTERIOR O UNA MODIFICACION DE EL.
ES93903313T 1992-02-05 1993-02-05 Reactivo en fase solida y dosificado anticorporal que lo utiliza. Expired - Lifetime ES2126644T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5432992 1992-02-05
JP23651792 1992-08-12

Publications (1)

Publication Number Publication Date
ES2126644T3 true ES2126644T3 (es) 1999-04-01

Family

ID=26395081

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93903313T Expired - Lifetime ES2126644T3 (es) 1992-02-05 1993-02-05 Reactivo en fase solida y dosificado anticorporal que lo utiliza.

Country Status (9)

Country Link
US (1) US5472883A (es)
EP (1) EP0600088B1 (es)
JP (1) JP2886983B2 (es)
AT (1) ATE175275T1 (es)
AU (1) AU666352B2 (es)
CA (1) CA2107557C (es)
DE (1) DE69322842T2 (es)
ES (1) ES2126644T3 (es)
WO (1) WO1993016387A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009363A1 (fr) * 1993-09-29 1995-04-06 Yamasa Corporation Procede de titrage de lipoproteine oxydee et applications de ce procede
US5998223A (en) * 1993-11-16 1999-12-07 Yamasa Corporation Method of assaying autoimmune anticardiolipin antibody and kit therefor
FR2723204B1 (fr) * 1994-08-01 1996-10-11 Orstom Procede de detection et/ou de dosage de compose(s) infectueux dans un materiau biologique et support utilise pour ledit procede
DE69528368T2 (de) * 1994-08-01 2003-05-22 Inst Rech Pour Le Dev Ird Pari Verfahren zur trennung und/oder identifikation und/oder quantifizierung von infektiösen materialen und träger zur durchführung dieses verfahrens
US6410775B1 (en) * 1995-06-07 2002-06-25 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US5874409A (en) * 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
JP2000505902A (ja) * 1996-12-05 2000-05-16 イデゴ・アーペーエス 生物学的流体中の標的分子をイムノアッセイにより検出するためのセンサー積層体及び多区画流体送達装置
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
US20050197283A1 (en) * 1998-10-04 2005-09-08 Vascular Biogenics Ltd. Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
US6777193B1 (en) * 2000-08-04 2004-08-17 Escuela Nacional De Ciencias Biologicas, Del Instituto Politecnico Nacional Methods for diagnostic and/or treatment of antiphospholipids antibodies-related diseases, and devices
ES2239532B1 (es) * 2004-02-06 2006-11-01 Proyecto De Biomedicina Cima S.L. Metodo para evaluar el riesgo y la predisposicion a desarrollar una patologia relacionada con la presencia de autoanticuerpos frente a epcr.
US7273998B2 (en) * 2004-09-15 2007-09-25 General Electric Company System and method for monitoring laser shock processing
NZ556065A (en) * 2005-01-24 2009-04-30 Univ Texas FC-fusion constructs binding to phosphatidylserine and their therapeutic use
EP1874334A4 (en) * 2005-04-15 2011-03-30 Vascular Biogenics Ltd COMPOSITIONS WITH BETA 2-GLYCOPROTEIN I-PEPTIDES FOR THE PREVENTION AND / OR TREATMENT OF VASCULAR DISEASES
IT202100002306A1 (it) * 2021-02-03 2022-08-03 Univ Degli Studi Roma La Sapienza Procedimento e kit per la diagnosi in vitro della sindrome da anticorpi anti-fosfolipidi

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299916A (en) * 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
JPS5915861A (ja) * 1982-07-19 1984-01-26 Konishiroku Photo Ind Co Ltd 免疫分析用材料
US4552633A (en) * 1982-09-29 1985-11-12 Japan Atomic Energy Research Institute Fine particulate for use in clinical testing and a process for producing thereof
JPS5958004A (ja) * 1982-09-29 1984-04-03 Japan Atom Energy Res Inst 臨床検査用微粒子の製造方法
JPS6091983A (ja) * 1983-10-25 1985-05-23 Susumu Kogyo Kk タンパク質固定用膜担体およびその製造方法
SE8401437D0 (sv) * 1984-03-14 1984-03-14 Sven Gothe Ytmodifierade plastytor och dess tillempningar for immunoassays (ia)
JPS60260857A (ja) * 1984-06-08 1985-12-24 Sumitomo Bakelite Co Ltd 固相免疫測定法用成形品
JPS62123359A (ja) * 1985-11-22 1987-06-04 Sumitomo Bakelite Co Ltd 固相免疫測定用成形品及びその製造方法
JPS6318268A (ja) * 1986-07-10 1988-01-26 Olympus Optical Co Ltd 生化学分析用担体およびその製造方法
JPH02504550A (ja) * 1987-08-04 1990-12-20 ダルーガー，ソーラブ 写真免疫蛍光分析
JPH01223352A (ja) * 1988-01-11 1989-09-06 General Biometrics Inc 固相酵素免疫検定システムおよび方法
US5028657A (en) * 1988-07-18 1991-07-02 Industrial Research Technology Institute Use of plasma to immobilize protein on polymeric surfaces
US5171779A (en) * 1988-07-18 1992-12-15 Industrial Technology Research Institute Use of plasma to immobilize protein on polymeric surfaces
JPH0271152A (ja) * 1988-09-07 1990-03-09 Terumo Corp 固相免疫測定用成形品の製造法
US5102798A (en) * 1988-09-08 1992-04-07 Allage Associates Surface functionalized Langmuir-Blodgett films for immobilization of active moieties
US5016644A (en) * 1989-01-10 1991-05-21 La Mina Ltd. Urine testing module and method of collecting urine antigen
US4961432A (en) * 1989-01-10 1990-10-09 Cancer Diagnostics, Inc. Modular fluid sample preparation assembly
ES2099699T3 (es) * 1989-05-02 1997-06-01 Abbott Lab Fijacion covalente de los miembros de union especificos a las fases solidas.
US5133363A (en) * 1989-06-21 1992-07-28 La Mina Ltd. Modular multiple fluid sample preparation assembly
JP2714862B2 (ja) * 1989-08-11 1998-02-16 日東電工株式会社 免疫学的測定法
EP0425268A3 (en) * 1989-10-27 1992-03-25 Teijin Limited Phosphazene polymer carrier for biologically active substance
EP0474849B1 (en) * 1990-04-06 1995-09-13 Yamasa Shoyu Co., Ltd. Methods for determining antiphospholipid antibodies

Also Published As

Publication number Publication date
CA2107557C (en) 1999-07-20
DE69322842D1 (de) 1999-02-11
EP0600088B1 (en) 1998-12-30
US5472883A (en) 1995-12-05
EP0600088A4 (en) 1996-08-21
AU3463393A (en) 1993-09-03
JP2886983B2 (ja) 1999-04-26
AU666352B2 (en) 1996-02-08
WO1993016387A1 (fr) 1993-08-19
ATE175275T1 (de) 1999-01-15
CA2107557A1 (en) 1993-08-06
DE69322842T2 (de) 1999-05-20
EP0600088A1 (en) 1994-06-08

Similar Documents

Publication Publication Date Title
ES2126644T3 (es) Reactivo en fase solida y dosificado anticorporal que lo utiliza.
DE3883831D1 (de) Magnetoresistiver Sensor mit antiferromagnetischem Film.
ATE71411T1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
DE3861063D1 (de) Unabhaengige aufladevorrichtung fuer transportflugzeuge.
DK157805C (da) Apparat til transport af tung last.
DE3867600D1 (de) Verbrennungsvorrichtung fuer pulverisierte kohle.
DE3762228D1 (de) Rollenbahn fuer fahrzeugkarosserie-transportschlitten.
ATA74890A (de) Abscheider fuer leichtfluessigkeiten
DE3684965D1 (de) Elektronische abgleichsvorrichtung zur belichtungssteuerung mit zwei photodetektoren.
DE3682082D1 (de) Fuehler fuer luft/kraftstoffverhaeltnis.
JPS5332114A (en) Quantitative determination of antigen and antibody
DE3874913D1 (de) Beleuchtungsvorrichtung fuer ein mehrfarbenkopiergeraet.
IT8921152A0 (it) Unita' di trasporto stradale a carrozzeria portante deponibile.
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
IT8740140A0 (it) Dispositivo meccanico conglobante le funzioni di differenziale autobloccante e ripartitore di coppia secondo un rapporto determinato tra i due semialberi
DE3861917D1 (de) Tiefladewaggon fuer huckepackverkehr.
IL101602A0 (en) Anti-viral hybrid antibodies
DE69205430D1 (de) Wiederverwendbares sammelmagazin mit tragwalzen fuer lichtempfindliches material.
DE3688481D1 (de) Hochkontrast-photolackentwickler mit verbesserter empfindlichkeit.
DE68900535D1 (de) Fahrzeug fuer den guetertransport.
JPS5942038U (ja) ハイブリツドｉｃの搬送用ベルトコンベヤ
DE3773183D1 (de) Quelle fuer geladene teilchen.
DE3880790D1 (de) Ultrareines zirkonium-zinn-innenauskleidungsmaterial fuer kernbrennstoffelemente.
IT7920477A0 (it) Dispositivo per il trasporto e il capovolgimento di un carico per mezzo di un carrello elevatore a forcella.
DK365378A (da) Stablevogn med gaffel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 600088

Country of ref document: ES